The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Kaplan, Muhammet; Oruc, Zeynep; Gumus, MAHMUT; Ozaydm, Sukru; ELKIRAN, EMİN; Dine, Nur; Sakin, Abdullah; Berk, Veli; Akman, Tulay; Aytekin, Aydin; Yazilitas, Dogan; Dane, Faysal; Imamoglu, Goksen; Cubukce, Erdem; Isikdogan, Abdurrahman

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Atıf İçin Kopyala

Kaplan M. A. , Oruc Z., Gumus M. , Ozaydm S., ELKIRAN E. T. , Dine N. S. , et al.

JOURNAL OF BUON, cilt.24, ss.1081-1086, 2019 (SCI İndekslerine Giren Dergi)

Cilt numarası: 24 Konu: 3
Basım Tarihi: 2019
Dergi Adı: JOURNAL OF BUON
Sayfa Sayısı: ss.1081-1086

Özet

Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-based chemotherapy and paclitaxel.